Stemedica
Cell Technologies engages in the development and manufacture of adult stem cells... Read moreStemedica
Cell Technologies engages in the development and manufacture of adult stem cells... Read more
CEO
Maynard A. Howe
News
Jan 19, 2023
Business Wire
Press Release: Stemedica : Stemedica Initiating Phase IIb/III Clinical Trial for Patients with Chronic Ischemic Stroke
Aug 23, 2021
Markets Insider
Stemedica: StemProtein Awarded U.S. Patent for Biodegradable Microneedle Device
Aug 04, 2021
Markets Insider
Stemedica: Stemedica Opens Enrollment in Phase II Clinical Trial for COVID-19
May 24, 2021
Markets Insider
Stemedica: Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Sep 29, 2020
Pharmabiz
Stemedica: Stemedica Cell receives US FDA nod to begin phase II trial using itMSC Therapy for COVID19 patients
Jan 07, 2019
PharmiWeb
Stemedica: Stemedica Cell Technologies Reports Positive Data in Phase I/IIa Study of Allogeneic Stem Cells for Ischemic Stroke
Nov 01, 2016
PR Newswire
Press Release: Stemedica : University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica's Stem Cells for Alzheimer's disease
Oct 26, 2016
PRLog
Press Release: Stemedica : Society for Neuroscience (SfN) Selects Stemedica International's Research as a Hot Topic
Aug 17, 2016
Contract Pharma
Stemedica: Cryoport Expands Cold Chain Agreement with Stemedica
Aug 15, 2016
BioSpace
Stemedica: Three CardioCell-Sponsored Studies Reveal Results At The European Society of Cardiology Congress 2016
Stemedica Competitors
1
2
3
4
5
6
7
8
9
10